Innate lymphoid cells (ILCs) are lymphocyte-like cells that lack T cell or B cell antigen receptors and mediate protective and repair functions through cytokine secretion. Among these, type 2 ILCs (ILC2 cells) are able to produce type 2 cytokines. We report the existence of an inflammatory ILC2 (iILC2) population responsive to interleukin 25 (IL-25) that complemented IL-33-responsive natural ILC2 (nILC2) cells. iILC2 cells developed into nILC2-like cells in vitro and in vivo and contributed to the expulsion of Nippostrongylus brasiliensis. They also acquired IL-17-producing ability and provided partial protection against Candida albicans. We propose that iILC2 cells are transient progenitors of ILCs mobilized by inflammation and infection that develop into nILC2-like cells or ILC3-like cells and contribute to immunity to both helminths and fungi.
Innate lymphoid cells (ILCs) are lymphocyte-like cells that lack specific antigen receptors yet produce effector cytokines that match those of CD4 + helper T cell subsets. ILCs are classified into three major groups on the basis of their cytokine-producing potential: interferon-γ (IFN-γ)-producing type 1 ILCs (ILC1 cells); interleukin 13 (IL-13)-and IL-5-producing type 2 ILCs (ILC2 cells); and IL-17-or IL-22-producing type 3 ILCs (ILC3 cells) [1] [2] [3] . ILCs provide immunity against infectious agents, participate in inflammatory responses and mediate lymphoid organogenesis and tissue repair, particularly at mucosal barriers. They provide early control of pathogen invasion in a non-antigen-specific manner and are often a critical first line of immune defense.
ILC2 cells have an important role in type 2 immunity. They were independently described by several groups and were designated 'natural helper cells' , 'nuocytes' or 'innate helper 2 cells' [4] [5] [6] . Although there are some differences between these cells in their tissue localization and surface marker patterns, they are considered by many to represent a single cell type, now designated 'ILC2' on the basis of their production of type 2 cytokines and associated functions. A separate IL-25-responsive innate cell population has been described, called 'multipotent progenitors' (MPP type2 cells) 7 . MPP type2 cells contribute to helminth immunity but, in contrast to ILC2 cells, can develop into monocytes and macrophages or mast cells and are of the myeloid lineage rather than the lymphoid lineage 8 .
ILC2 cells have a critical role in immune responses to helminths, such as Nippostongylus brasiliensis. Dysfunction of ILC2 cells causes a substantial delay in worm expulsion 9 . ILC2 cells also participate in allergic inflammation. They mediate influenza virus-induced airway hyper-reactivity and protease allergen-induced eosinophilic lung inflammation 10, 11 and have been reported to promote allergic atopic dermatitis in humans 12 . ILC2 cells also function in tissue remodeling. They contribute to lung tissue repair during viral infection and mediate hepatic fibrosis 13, 14 .
ILC2 cells act through diverse effector pathways. Through the production of IL-13, they induce epithelial goblet cells to secrete mucus and contribute to tissue repair by producing amphiregulin 10, 13 . By secreting IL-5 and IL-9, ILC2 cells control eosinophil homeostasis and mast cell activation 15, 16 . It has been reported that ILC2 cells promote the B cell production of antibody and activation of CD4 + T cells [17] [18] [19] .
ILC2 development depends on the action of the transcription factor Id2 and expression of the IL-2 receptor γ-chain (the common γ-chain (γ c )), but not on the RAG recombinase 1, 18 . The transcription factor GATA-3 is indispensable for the development and survival of ILC2 cells 19, 20 . The transcription factors RORα and TCF-1 are also required for the generation of ILC2 cells 21, 22 . Additionally, the transcriptional determinant Gfi1 has been reported to promote the development of ILC2 cells and to regulate their cytokineproducing phenotype 23 .
Two epithelial cell-derived cytokines, IL-25 and IL-33, have been reported to be crucial for the induction and activation of ILC2 cells both in humans and in mice 24, 25 . IL-25 is a member of the IL-17 family that is associated with type 2 helper T cell (T H 2 cell)-like 1 6 2 VOLUME 16 NUMBER 2 FEBRUARY 2015 nature immunology A r t i c l e s immune responses. IL-33 is a member of the IL-1 family, and its receptor, ST2, is expressed on both T H 2 cells and ILC2 cells, as well as on mast cells, basophils and eosinophils 26 . IL-25 and IL-33 are important in anti-helminth immunity and allergic inflammation. Infection with N. brasiliensis triggers epithelial cells to release IL-25 and IL-33, which in turn activate ILC2 cells, causing their population expansion and cytokine production 27 . ILC2 populations with different tissue distribution and cytokine receptor-expression patterns have been reported to have different responsiveness to IL-25 or IL-33. Some ILC2 populations are thought to respond to either IL-25 or IL-33; and some, to both. However, the relationship between IL-25-responsive ILC2 cells and IL-33-responsive ILC2 cells is still unclear.
Here we report an IL-25-responsive ILC2 cell population that expressed large amounts of the activation marker KLRG1 and the IL-25 receptor (IL-17RB) but did not express ST2. These cells had a phenotype distinct from those of both MPP type2 cells and conventional ILC2 cells in the lungs. They proliferated in response to IL-25 but not in response to IL-33. They developed into ST2 + ILC2 cells both in vitro and in vivo. These KLRG1 hi cells were elicited early in the course of infection with N. brasiliensis, before the proliferation of lung-resident ILC2 cells, and became ILC2-like cells during such infection. KLRG1 hi cells also expressed intermediate amounts of RORγt, whereas IL-33-responsive ILC2 cells did not. KLRG1 hi cells had the potential to produce IL-17 and were able to develop into ILC3-like cells either under culture conditions like those that promote polarization into the T H 17 subset of helper T cells or in response to infection with Candida albicans. We propose that the IL-33responsive ILC2 cells resident at steady state in the lungs and fat-associated lymphoid tissues be designated 'homeostatic ILC2 cells' or 'natural ILC2 cells' (nILC2 cells), while the KLRG1 hi cells that appeared only after stimulation with IL-25 or infection be designated 'inflammatory ILC2 cells' (iILC2 cells).
RESULTS

Induction of a lineage-negative KLRG1 hi cell population by IL-25
We treated wild-type mice intraperitoneally for 3 d with recombinant IL-33 or IL-25 and analyzed lung leukocytes for ILC surface markers ( Fig. 1a) . In naive mice, lung ILC2 cells, characterized as lacking lineage markers (Lin − ) and ST2 + , increased two-to threefold in number in response to IL-33 ( Fig. 1a-c) . A Lin − ST2 − cell population, barely detectable in the lungs of untreated or IL-33-treated mice, appeared after treatment with IL-25 ( Fig. 1a) . This IL-25-induced cell population had abundant expression of KLRG1 ( Fig. 1a,b) . Although KLRG1 was expressed on resident ILC2 cells, its intensity was substantially less on those cells than on the IL-25-responsive population ( Fig. 1a,b) . We designated the Lin − ST2 + KLRG1 int cells 'nILC2 cells' and the Lin − ST2 − KLRG1 hi cells 'iILC2 cells' .
The lungs of naive mice contain 4 × 10 3 to 5 × 10 3 nILC2 cells ( Fig. 1c) . Treatment with IL-33 increased that to ~1 × 10 4 , while IL-25 caused a statistically insignificant increase in lung nILC2 cells ( Fig. 1c) . In contrast, iILC2 cells, undetectable in the lungs of untreated or IL-33treated mice, were present at an abundance of more than 4 × 10 4 cells per mouse in the lungs of IL-25-treated mice ( Fig. 1c) . iILC2 cells were all positive for the proliferation marker Ki67 (Fig. 1d) , which indicated they had proliferated very rapidly in the IL-25-treated mice. We also detected iILC2 cells in spleen, mesenteric lymph nodes (MLNs) and liver, but detected few in the bone marrow ( Supplementary Fig. 1) .
Phenotypically, iILC2 cells were c-Kit + CD44 + and had lower expression of the receptor IL-7Rα and the alloantigen Thy-1 than did nILC2 cells ( Fig. 1e) . Most iILC2 cells lacked the lineage marker Sca-1, which was uniformly expressed on nILC2 cells (Fig. 1e) .
Notably, iILC2 cells were IL-17RB hi , whereas nILC2 cells hade much lower expression of IL-17RB ( Fig. 1e) . Thus, iILC2 cells were ST2 − IL-17RB + and responded to IL-25 but not to IL-33, whereas nILC2 cells were ST2 + and responded mainly to IL-33. Treatment with IL-25 did not elicit iILC2 cells in IL-17RB-deficient (Il17rb −/− ) mice but did so in ST2-deficient (Il1rl1 −/− ) mice ( Fig. 1f) .
Previous studies have shown that 7 d of treatment with IL-25 elicits the myeloid population of MPP type2 cells in MLNs 7 . MPP type2 cells are characterized as Lin − IL-7Rα − Thy-1 − ST2 − c-Kit + . To address whether MPP type2 cells also appear in the lungs and to clarify the relationship among iILC2 cells, nILC2 cells and MPP type2 cells, we assessed the presence of these three populations among lung leukocytes in untreated mice and mice treated with IL-25 daily for 3 d or 7 d (Fig. 1g) . In untreated mice, we observed only nILC2 (Lin − IL-7Rα + Thy-1 hi ST2 + KLRG1 int ) cells. 3 d of administration of IL-25 induced large numbers of iILC2 (Lin − IL-7Rα + Thy-1 lo ST2 − KLRG1 hi ) cells but still no MPP type2 cells. In mice treated for7 d with IL-25, while iILC2 cells were still present, we observed the induction of MPP type2 (Lin − IL-7Rα − Thy-1 − ST2 − c-Kit + ) cells. Thus, IL-25 induced at least two cell populations in the lungs, lymphoid iILC2 cells and myeloid MPP type2 cells, depending on the duration of treatment.
iILC2 development depends on g c and IL-7Ra
We assessed whether iILC2 cells exist in mice deficient in the recombinase component RAG-2 (Rag2 −/− mice) or in Rag2 −/− mice also deficient in γ c (Rag2 −/− Il2rg −/− mice). Rag2 −/− mice treated with IL-25 produced iILC2 cells in the lungs and MLNs ( Fig. 2a) . Many more iILC2 cells were elicited by IL-25 in Rag2 −/− mice than in wild-type mice: in the lungs, ~5 × 10 5 iILC2 cells appeared in Rag2 −/− mice treated with IL-25 ( Fig. 2a) , compared with fewer than 5 × 10 4 in wild-type mice ( Fig. 1c) . MLNs are much smaller in RAG-2deficient mice than in wild-type mice; however, MLNs of Rag2 −/− mice become enlarged after IL-25 treatment. 67% of the total MLN cells in Rag2 −/− mice were iILC2 cells, with numbers in excess of 1 × 10 6 ( Fig. 2a) . In contrast, iILC2 cells were totally absent in Rag2 −/− Il2rg −/− mice treated with IL-25 ( Fig. 2b) , which indicated that iILC2 cells were γ c dependent.
All ILCs, other than classic IL-7Rα − NK1.1 + natural killer cells, require IL-7Rα for their development. Treating IL-7Rα-deficient (Il7ra −/− ) mice with IL-25 led to substantially fewer iILC2 cells than did treatment of wild-type mice ( Fig. 2c,d) , which indicated that IL-7Rα was critical for the induction of iILC2 cells by IL-25. Notably, while we detected no nILC2 cells in Il7ra −/− mice, iILC2 cells were not totally abolished in IL-25-treated Il7ra −/− mice ( Fig. 2d) , which suggested that iILC2 cells and nILC2 cells might arise through somewhat different developmental pathways or that more than one cell population might have been present in the iILC2 'gate' .
We cultured the sorted iILC2 (Lin − ST2 − KLRG1 hi ) cells from IL-25treated wild-type mice in IL-2 plus IL-7 or, alternatively, in IL-3 plus the cytokine stem cell factor (SCF). iILC2 cells survived and proliferated in the presence of IL-2 plus IL-7 but died in the presence of IL-3 plus SCF ( Fig. 2e ). This pattern of responsiveness differed from that reported for MPP type2 cells, which further indicated that iILC2 cells were distinct from MPP type2 cells.
Production of type 2 cytokines by iILC2 cells
To quantify type 2 cytokine-producing cells, we generated 4C13R dual reporter mice, with transgenic expression (via a bacterial artificial chromosome) of the cyan fluorescent protein AmCyan under the control of Il4 regulatory elements and of the red fluorescent protein dsRed under the control of Il13 regulatory elements; in these mice, IL-4 production is reported by AmCyan and IL-13 production is reported by destabilized DsRed (Supplementary Fig. 2a ). These mice allow detection of IL-4-or IL-13-producing cells without in vitro stimulation. In naive 4C13R mice, ~2-9% of lung nILC2 cells produced IL-13, but few if any made IL-4 ( Fig. 3a and Supplementary Fig. 2b ). After the administration of IL-25, the frequency of IL-13-producing nILC2 cells rose to ~14%, but we observed no IL-4-production ( Fig. 3b) . Among iILC2 cells from IL-25-treated mice, ~31% were DsRed + ( Fig. 3b) , which indicated that they were producing IL-13. A few of those cells (~2%) were AmCyan + (Fig. 3b) . Thus, iILC2 cells shared with nILC2 cells the ability to make type 2 cytokines.
To further address the cytokine-producing ability of iILC2 cells, we purified them from IL-25-treated wild-type mice, cultured them for 3 d in IL-2, IL-7 and IL-25 and then stimulated the cells with IL-25, IL-33 or the phorbol ester PMA plus ionomycin ( Fig. 3c) . Consistent with the results obtained with 4C13R mice, some iILC2 on Lin − cells (gated at left) from the lungs of IL-25-treated B6 mice: red, nILC2 cells; blue, iILC2 cells; gray shaded curves, negative control for each marker (for example, Lin + IL-7Rα − cells were gated as a negative control for IL-7Rα expression). (f) Expression of lineage markers, Thy-1 and KLRG1 by lung leukocytes from wild-type (WT), Il17rb −/− or Il1rl1 −/− mice treated for 3 d with IL-25, analyzed by flow cytometry with gating on Lin − . Numbers adjacent to outlined areas indicate percent Thy-1 hi KLRG1 int cells (top left) and Thy-1 lo KLRG1 hi cells (bottom right). (g) Expression of ILC markers (along axes) by lung leukocytes from wild-type B6 mice left untreated (UT) or treated for 3 or 7 d (left margin) with IL-25, analyzed by flow cytometry with gating on Lin − Thy-1 − IL-7Rα − ST2 − c-Kit + (MPP type2 cells), Lin − Thy-1 lo IL-7Rα + ST2 − KLRG1 hi (iILC2 cells) or Lin − Thy-1 hi IL-7Rα + ST2 + KLRG1 int (nILC2 cells); numbers adjacent to outlined areas indicate percent cells in those gates. NS, not significant; *P ≤ 0.05 (unpaired two-tailed t test). Data are representative of three (a-e) or two (f,g) independent experiments with n = 3 mice per group in each (a-c; mean and s.e.m. in c), n = 2 mice in each (d,e) or n = 2 mice per group in each (f,g).
A r t i c l e s cells produced IL-13 even without simulation. PMA plus ionomycin induced the great majority of iILC2 cells to produce IL-4, IL-13 and IL-5. Unexpectedly, cultured iILC2 cells failed to respond to IL-25 but did produce IL-13 and IL-5 in response to IL-33; no IL-4 was produced in response to IL-33. Since iILC2 cells were sorted as ST2 − IL-17RB + cells, these results suggested that iILC2 cells might have changed their expression pattern of ST2 and IL-17RB when cultured in vitro. These results emphasized that ILC2 cells, while they produced only IL-13 and IL-5 in response to cytokines, were able to produce IL-4 when stimulated with PMA plus ionomycin.
Development of iILC2 cells into ST2 + nILC2-like cells
The altered responsiveness of iILC2 cells to IL-33 and IL-25 suggested they might have upregulated ST2 expression and downregulated IL-17RB expression during culture. We sorted iILC2 cells from IL-25-treated Rag2 −/− donors, cultured them in various cytokine combinations and measured ST2 and IL-17RB expression on day 7. The starting cell population was ST2 − IL-17RB + (Fig. 4a,b) . 7 d of culture in IL-2 and IL-7 resulted in the great majority becoming ST2 + (Fig. 4a) . The addition of IL-25 or IL-33 or both to the culture led to even higher expression of ST2 among those cells ( Fig. 4a) . Culture in IL-2 and IL-7 did not change the expression of IL-17RB on day 7; the addition of IL-33 or IL-33 plus IL-25 extinguished IL-17RB expression on cultured iILC2 cells, whereas the addition of IL-25 only led to a portion of cells having retained IL-17RB expression ( Fig. 4b) . iILC2 cells grew and proliferated in each of the culture conditions, although yields were better when either or both IL-25 and IL-33 were present (data not shown). Mesenteric nILC2 cells have been reported to respond to IL-2 plus IL-25 with upregulation of IL-17RB expression 4 . However, nILC2-like cells derived from iILC2 cells by culture in IL-7 and IL-33, which had downregulated IL-17RB, failed to re-express IL-17RB in response to IL-2 and IL-25 (Supplementary Fig. 3) .
To exclude the possibility that the purified iILC2 cells were contaminated with nILC2 cells, which might have overgrown to become the predominant population during the 7 d of culture, we performed a coculture experiment. We sort-purified CD45.1 + iILC2 cells and CD45.2 + nILC2 cells and mixed them at a ratio of 2.7:1 (iILC2 cells to nILC2 cells). After 7 d of culture in IL-2, IL-7, IL-25 and IL-33, the ratio of CD45.1 + cells to CD45.2 + cells remained essentially the same (2.8:1), but all the cells were ST2 + KLRG1 int (Fig. 4c) , which not only indicated that the two cell populations expanded to the same extent but also established that iILC2 cells converted to cells with a nILC2 phenotype.
While the majority of KLRG1 hi cells were ST2 − at day 3 after in vivo treatment with IL-25, a small proportion of these cells were ST2 + or ST2 lo (Fig. 1g) . By day 7 of in vivo IL-25 treatment, ST2 − and ST2 + cells were present in equal proportions among the KLRG1 hi population (Fig. 1g) . This result suggested that iILC2 cells gave rise to cells of an nILC2 phenotype in vivo. To address this possibility, we transferred sorted iILC2 cells into Rag2 −/− Il2rg −/− mice. 8 d later, more than 60% of transferred cells in the lungs had become ST2 + nILC2-like cells ( Fig. 4d) . We propose that IL-25-induced iILC2 cells are transient progenitors of nILC2 cells or of cells similar to nILC2 cells.
Regulation of anti-helminth immunity by iILC2 cells
We investigated whether helminth infection elicits iILC2 cells. We infected wild-type mice (Fig. 5a ) or 4C13R reporter mice ( Supplementary Fig. 4a ) with N. brasiliensis and analyzed lung ILCs at various times. iILC2 cells first appeared on day 5 after infection; however, at that time, nILC2 cells had not yet proliferated ( Fig. 5a and Supplementary Fig. 4a) . Thereafter, the number of iILC2 cells decreased, while nILC2 cells increased in number ( Fig. 5a and Supplementary Fig. 4a ). On day 14, most iILC2 cells had disappeared, but nILC2 cells had increased three-to fourfold compared with their abundance in uninfected mice (Fig. 5a) . N. brasiliensis-activated nILC2 cells produced IL-13, and some produced IL-4, but iILC2 cells were better cytokine producers (Supplementary Fig. 4a) .
N. brasiliensis-induced iILC2 cells were IL-25 dependent; they were absent in infected Il17rb −/− mice (Fig. 5b,c) . The population expansion of nILC2 cells was also significantly impaired in Il17rb −/− mice (Fig. 5d) , which suggested that iILC2 cells made a substantial contribution to the number of nILC2 cells during infection with N. brasi liensis. Intestinal worm burden was substantially greater in Il17rb −/− mice than in wild-type mice (Fig. 5e) , which indicated that the IL-25dependent iILC2 cells were important for worm expulsion 5 .
The results reported above were consistent with the possibility that the N. brasiliensis-induced iILC2 cells were a transient progenitor population that developed into nILC2-like cells and participated in the expulsion of helminths. To assess this possibility, we transferred CD45.1 + nILC2 cells and CD45.2 + iILC2 cells together into npg A r t i c l e s Rag2 −/− Il2rg −/− mice and infected the recipient mice with N. brasiliensis. 14 d later, the ratio of CD45.1 + cells to CD45.2 + cells remained similar to that in the injected cell populations, but all the iILC2 cells had developed into IL-7Rα + Thy-1 hi ST2 + KLRG1 int nILC2-like cells (Fig. 5f) .
In addition, the transferred iILC2 cells developed into nILC2-like cells in the absence of nILC2 cells (Supplementary Fig. 4b) . These results indicated that iILC2 cells were indeed transient progenitors of nILC2 cells during helminth infection. We sought to determine whether iILC2 cells could protect mice against infection with N. brasiliensis. Rag2 −/− Il2rg −/− mice cannot expel worms of this parasite because of the absence of T cells and ILCs. Between day 7 and day 11 after infection of Rag2 −/− Il2rg −/− mice with N. brasiliensis, we detected many eggs in mouse feces (Fig. 5g) , and we observed adult worms in the intestine on day 14 (Fig. 5h) . The transfer of iILC2 cells into Rag2 −/− Il2rg −/− mice resulted in a significantly lower number of eggs in the feces and the worm burden in the intestine, comparable to that observed by the transfer of a similar number of nILC2 cells (Fig. 5g,h) , which indicated that iILC2 cells and/or their descendants were able to limit worm expansion.
Development of iILC2 cells into IL-17 producers
We compared the expression of GATA-3 and RORγt by lung iILC2 cells, lung nILC2 cells and small intestine lamina propria (siLP) ILC3 cells (Fig. 6a) . Both ILC2 cells and ILC3 cells expressed GATA-3, as reported 20 (Fig. 6a) . As expected, nILC2 cells expressed more GATA-3 than did ILC3 cells; iILC2 cells expressed even more GATA-3 than did nILC2 cells (Fig. 6a) . iILC2 cells also expressed an intermediate amount of RORγt, less than ILC3 cells, but significantly distinct from the GATA-3 expression of nILC2 cells (Fig. 6a) . In keeping with the presence of RORγt, a small proportion of freshly isolated IL-13producing iILC2 cells also produced IL-17 upon stimulation with PMA plus ionomycin (Fig. 6b) .
Naive CD4 + T cells can differentiate into diverse helper T cell subsets, either in response to distinct pathogenic pressure in vivo or under polarized culture conditions in vitro. We mimicked in vitro conditions for helper T cell differentiation in our cultures of iILC2 cells, although we omitted antigen-presenting cells. More than 50% of iILC2 cells cultured with IL-4, anti-IFN-γ and anti-IL-12 (T H 2 conditions), in addition to the usual iILC2 culture conditions, produced IL-13 and, upon stimulation with PMA plus ionomycin, ~90% of the cells produced IL-13 (Fig. 6c) . Among iILC2 cells cultured with the addition of IL-12 and anti-IL-4 (T H 1 conditions) or the cytokine TGF-β and IL-6 (T H 17 conditions), fewer produced IL-13 with or without PMA plus ionomycin (Fig. 6c) . This difference was particularly pronounced for IL-4 production induced by PMA plus ionomycin (Fig. 6c) . iILC2 cells cultured under any conditions failed to produce IFN-γ (Fig. 6c) . Impressively, 50% of iILC2 cells in 'T H 17' conditions produced IL-17 in response to PMA plus ionomycin, while fewer iILC2 cells cultured under 'T H 1' or 'T H 2' conditions were able to make IL-17 (Fig. 6c) . Most IL-17 producers also produced IL-13 (Fig. 6c) . Some cells cultured under 'T H 17' conditions produced IL-17 even without stimulation with PMA plus ionomycin (Fig. 6c) , a result we confirmed by measuring secreted IL-17 protein in the supernatants of cultured cells (Fig. 6d) .
To determine whether the potential of iILC2 cells to become double producers of both IL-13 and IL-17 was limited to a subset of these cells or was a general property, we sorted DsRed + and DsRed − iILC2 cells from IL-25-treated 4C13R mice and cultured them under 'T H 17' or 'T H 2' conditions. After culture, both groups were equivalent in their capacity to produce IL-17, although those cultured under 'T H 17' conditions were superior to those cultured under 'T H 2' conditions ( Fig. 6e) . We also used IL-17-RFP reporter mice (in which expression of red fluorescent protein (RFP) indicates expression of IL-17) in similar experiments. Both cells that produced IL-17 and those that did not produce IL-17, after stimulation PMA plus ionomycin, had the same potential to become cells that produced both IL-13 and IL-17 upon culture (Supplementary Fig. 5 ). This finding was consistent with the homogenous expression of RORγt in freshly isolated iILC2 cells (Fig. 6a) . Thus, iILC2 cells expressed both GATA-3 and RORγt. They produced IL-13 and were also able to produce IL-17 under certain culture conditions in vitro.
We also investigated whether nILC2 cells had such plasticity as well. When cultured under 'T H 1' , 'T H 2' or 'T H 17' conditions, only ~2% to 5% of nILC2 cells produced IL-17 upon stimulation with PMA plus ionomycin (Supplementary Fig. 6 ). This result was independent of culture conditions (Supplementary Fig. 6 ), which indicated that nILC2 cells had less capacity to develop into IL-17 producers than did iILC2 cells.
Contribution of iILC2 cells to antifungal immunity
Since iILC2 cells were able to develop into IL-17 producers in vitro, we sought to determine whether they had a role in controlling IL-17sensitive pathogens. A published study has shown that IL-17-producing ILC3 cells are important for protection after oral infection with C. albicans 28 . We infected wild-type, Rag2 −/− and Rag2 −/− Il2rg −/− mice sublingually with C. albicans. Both wild-type and Rag2 −/− mice lost ~10% of their body weight by 1-2 d after infection but recovered completely (Fig. 7a) . In contrast, Rag2 −/− Il2rg −/− mice displayed continued weight loss and all died by day 7 of infection ( Fig. 7a,d) . On day 6, we detected a large number of C. albicans in the tongue tissue of Rag2 −/− Il2rg −/− mice but not in that of wild-type or Rag2 −/− mice (Fig. 7b) . ILCs from tongue-draining lymph nodes of infected Rag2 −/− mice proliferated much more than did those of uninfected mice (Supplementary Fig. 7) , which indicated that after oral infection with C. albicans, γ c -dependent cells, presumably ILCs, had a major role in the control of infection. In addition, ~35% of the ILCs expressed IL-17RB, and a portion of these cells were also KLRG1 + (Supplementary Fig. 7) , which suggested that the IL-25-responsive ILCs might have had some role in the innate lymphocyte response to infection with C. albicans.
We transferred 0.5 × 10 6 or 1.2 × 10 6 iILC2 cells into Rag2 −/− Il2rg −/− mice, followed by sublingual infection of the recipients with C. albicans. (Fig. 7c) . iILC2 cells also improved survival by 4 d (Fig. 7d) . The abundance of C. albicans in the tongue tissue was lower in the two groups that received iILC2 cells than in mice that did not receive cells, with the group that had received 9 × 10 5 cells in another experiment showing a lower number of C. albicans in the tongue (Fig. 7e) ; this confirmed that iILC2 cells were able to provide partial protection against the pathogen.
There was no detectable IL-17 mRNA in Rag2 −/− Il2rg −/− mice that did not receive cells; in contrast, IL-17 mRNA was readily detectable in the tongues of mice that had received iILC2 cells, being greater in the tongues of mice that had received a larger number of iILC2 cells (Fig. 7f) . However, the transfer of iILC2 cells did not enhance IL-13 expression in the tongue tissue ( Fig. 7f) . We also analyzed the cytokine production by transferred iILC2 cells in the lungs of infected mice by flow cytometry. 5 d after transfer into C. albicans-infected mice, iILC2 cells were producing IL-17 but not IL-13 (Fig. 7g) , which indicated that they had become ILC3-like cells. Thus, iILC2 cells displayed a degree of in vivo plasticity and were able to provide partial protection against C. albicans.
DISCUSSION
ILCs are a first line of defense in many infectious models. They reside in barrier tissues and respond quickly to infections. Transient activation and expansion in the number of ILCs occurs upon stimulation with cytokines or pathogens. ILC2 cells show cytokine-based activation and population expansion in response to IL-25 and/or IL-33. Whether the same cell populations respond to the two different cytokines had not been clarified. In the original report of nuocytes 5 , their heterogeneous expression of ST2 and IL-17RB could have been due to a mixture of separate cell populations: IL-17RB-expressing ILC2 cells and ST2-expressing ILC2 cells. Here we have presented evidence that responsiveness to IL-25 and IL-33 is a property of distinct cell types and propose that two ILC2 developmental pathways exist: a natural or homeostatic ILC2 (nILC2) pathway and an inflammatory ILC2 (iILC2) pathway.
In naive mice, ST2 + nILC2 cells were resident in the lungs and other tissues and became cytokine producers and expanded moderately in number in response to IL-33 stimulation. These cells initiated IL-13 production quickly after infection with N. brasiliensis, although they showed little expansion in number until after day 5. A second population of IL-13-producing ILCs arose in response to treatment with IL-25. These IL-17RB + cells lacked ST2 and expressed large amounts of KLRG1. We have designated these 'iILC2 cells' . iILC2 cells were undetectable in the lungs and in most other peripheral tissues in naive mice but showed massive elicitation in response to treatment with IL-25, a result that was even greater in Rag2 −/− mice. iILC2 cells appeared by day 5 of infection with N. brasiliensis, before the induction of T H 2 cells or the population expansion of nILC2 cells. Expansion in the number of nILC2 cells in N. brasiliensis-infected mice was significantly impaired in Il17rb −/− mice, which lacked iILC2 cells. On the basis of their phenotypic changes in transfer experiments, we concluded that iILC2 cells became nILC2-like cells during infection with N. brasiliensis. Thus, IL-25-induced iILC2 cells acted as transient progenitors of nILC2-like cells. Since the number of nILC2 cells at barrier surfaces at steady state was low and their proliferation was both slow and limited, iILC2 cells seem to be an important source of ILC2 cells to combat helminth infection.
The development of iILC2 cells was dependent on the expression of γ c ; iILC2 cells expressed IL-7Rα, as did nILC2 cells. iILC2 cells were induced normally in mice that lacked ST2, and nILC2 numbers were normal in mice that lacked IL-17RB. This indicated that the development of these two populations was independent of the 'alternative' cytokines.
The cytokine receptor expression and responsiveness pattern of iILC2 cells was dynamic. In vitro, highly purified iILC2 cells quickly acquired responsiveness to ST2 and IL-33 while they lost responsiveness npg to IL-25 and expression of IL-17RB, particularly when cultured in the presence of IL-33. When iILC2 cells were transferred into untreated mice, they became ST2 + nILC2-like cells in the lungs. GATA-3 expression and activation of the transcription factors STAT5 and NF-κB are essential for inducing T cell antigen receptorindependent ST2 expression in T H 2 cells 26 . A similar requirement probably exists in ILC2 cells. IL-25-induced iILC2 cells expressed very large amounts of GATA-3, as did nILC2 cells; IL-7 activates STAT5 in both cell types; and both IL-25 and IL-33 trigger activation of NF-κB. Thus, in vitro induction of ST2 expression on iILC2 cells in response to the STAT5 activators IL-2 and IL-7 and in response to the addition of either IL-25 or IL-33 would seem reasonable.
Important differences between iILC2 cells and nILC2 cells were that iILC2 cells expressed an intermediate level (between the amounts for nILC2 and ILC3) of RORγt, whereas nILC2 cells did not. Moreover, we identified nILC2 cells in the lungs and fat-associated lymphoid tissues but did not identify as many in the spleen or liver, while iILC2 cells were present in many sites, including lung, MLNs, spleen, liver and bone marrow, after treatment with IL-25.
Effector CD4 + helper T cells have the ability to alter their cytokineproducing phenotype in response to infectious challenges or cytokine exposure 29 . Whether various types of ILCs also have plasticity or flexibility in their cytokine-producing potential is unknown. Generally, ILCs are considered to be terminally differentiated cells. Most are resident in barrier tissues, and some constitutively produce cytokines. It has been reported that deficiency in Gfi1 leads ILC2 cells to lose their restricted cytokine-production phenotype; these cells can produce both IL-13 and IL-17 upon stimulation with PMA plus ionomycin, which suggests that ILCs may have plasticity in their cytokineproducing potential. We found here that iILC2 cells displayed a degree of plasticity or multipotentiality. In contrast to nILC2 cells, they expressed both GATA-3 and RORγt and had the ability to develop into either nILC2-like cells or ILC3-like cells.
We propose that there are two ILC2 developmental pathways: one that gives rise to tissue-resident nILC2 cells, and one that gives rise to iILC2 cells. We have clarified the relationship between IL-33-responsive ILC2 cells and IL-25-responsive ILC2 cells and demonstrated that IL-17RB-expressing iILC2 cells and their immediate progenitors were precursors of an ST2-expressing ILC2 population during inflammation and infection. We have also reported that iILC2 cells displayed the ability to be converted into distinct cytokine producers. Although ILCs lack antigen-specific receptors, they 'read' and distinguish types of microbial pathogens through epithelial cell-derived cytokines to react properly and to orchestrate immune responses.
METhODS
Methods and any associated references are available in the online version of the paper.
